Vitango - to alleviate stress and anxiety 30 coated tablets 200 mg

Product Description

Therapeutic indications. A traditional herbal medicinal product based exclusively on long-term use and whose therapeutic effect has not been demonstrated in controlled clinical studies. It is indicated for the temporary relief of symptoms associated with stress, such as fatigue, exhaustion, and mild anxiety.

Contraindications. Hypersensitivity to the active substance or to any of the excipients. Children under 12 years of age. Renal or hepatic insufficiency. Pregnancy and breastfeeding.

Special warnings and special precautions for use. Patients with signs and symptoms of depression should consult their doctor for appropriate treatment.
Use in children under 12 years of age and in patients with renal or hepatic impairment is contraindicated since there are no adequate data for these patient groups.
Consult a physician or qualified healthcare professional if symptoms persist while using this medicine or if adverse reactions not listed in the package leaflet occur.
Keep out of the reach and sight of children.

Interactions with other medicinal products and other forms of interaction. No information is available regarding possible interactions with other medicinal products. If the patient is already undergoing treatment with other medications, it is necessary to take the product after consulting your doctor.
Avoid concomitant use of other products containing alcohol or acting on the central nervous system.
Rhodiola rosea extracts are potential inhibitors of the CYP450 enzyme, although pharmacological interactions have not been observed in humans to date.

Pregnancy and breastfeeding. This product is contraindicated during pregnancy and breastfeeding, since no data are available for this group of patients.

Effects on the ability to drive and use machines. No studies on the ability to drive and use machines have been performed.

Undesirable effects. Hypersensitivity reactions and hypoglycemia have been reported.

Overdose. No cases of overdose have been reported.

QUALITATIVE AND QUANTITATIVE COMPOSITION
One film-coated tablet contains: 200 mg dry extract of Rhodiola rosea root (1.5 – 5 : 1) (WS® 1375) (equivalent to 300-1000 mg of Rhodiola rosea root and rhizome). Extraction agent: ethanol 60% (m/m).
Excipients: Microcrystalline cellulose, croscarmellose sodium, precipitated silica, magnesium stearate, hypromellose, stearic acid, red iron oxide, titanium dioxide, antifoam emulsion.

DOSAGE AND METHOD OF ADMINISTRATION
2 tablets per day, one before breakfast and one before lunch, to be taken with a glass of water, preferably 30 minutes before food.
Duration of treatment: The maximum duration of therapy is 14 days. If symptoms worsen or persist during use of the medicine, contact a doctor.
Children under 12 years: Use in children under 12 years is contraindicated.